China Resources Pharmaceutical Group Limited (3320.HK)
HKD 5.29
(0.0%)
HKD 5.29
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 168.46 Billion HKD | 12.13% |
| 2022 | 150.23 Billion HKD | -1.61% |
| 2021 | 152.68 Billion HKD | 18.65% |
| 2020 | 128.69 Billion HKD | 7.38% |
| 2019 | 119.84 Billion HKD | 3.57% |
| 2018 | 115.71 Billion HKD | 18.54% |
| 2017 | 97.61 Billion HKD | 22.51% |
| 2016 | 79.68 Billion HKD | -8.73% |
| 2015 | 87.3 Billion HKD | 3.14% |
| 2014 | 84.64 Billion HKD | 17.28% |
| 2013 | 72.17 Billion HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 181.85 Billion HKD | 0.0% |
| 2023 FY | 168.46 Billion HKD | 12.13% |
| 2023 Q4 | 153.79 Billion HKD | 0.0% |
| 2023 Q2 | 177.34 Billion HKD | 0.0% |
| 2022 FY | 150.23 Billion HKD | -1.61% |
| 2022 Q2 | 163.26 Billion HKD | 0.0% |
| 2022 Q4 | 150.23 Billion HKD | 0.0% |
| 2021 Q4 | 152.68 Billion HKD | 0.0% |
| 2021 Q2 | 149.73 Billion HKD | 0.0% |
| 2021 FY | 152.68 Billion HKD | 18.65% |
| 2020 Q4 | 128.69 Billion HKD | 0.0% |
| 2020 Q2 | 126.72 Billion HKD | 0.0% |
| 2020 FY | 128.69 Billion HKD | 7.38% |
| 2019 Q4 | 119.84 Billion HKD | 0.0% |
| 2019 FY | 119.84 Billion HKD | 3.57% |
| 2019 Q2 | 130.3 Billion HKD | 0.0% |
| 2018 FY | 115.71 Billion HKD | 18.54% |
| 2018 Q4 | 115.71 Billion HKD | 0.0% |
| 2018 Q2 | 105.55 Billion HKD | 0.0% |
| 2017 Q4 | 97.61 Billion HKD | 0.0% |
| 2017 FY | 97.61 Billion HKD | 22.51% |
| 2017 Q2 | 92.78 Billion HKD | 0.0% |
| 2016 Q2 | 86.21 Billion HKD | 0.0% |
| 2016 Q4 | 79.68 Billion HKD | 0.0% |
| 2016 FY | 79.68 Billion HKD | -8.73% |
| 2015 FY | 87.3 Billion HKD | 3.14% |
| 2015 Q4 | 87.3 Billion HKD | 0.0% |
| 2014 FY | 84.64 Billion HKD | 17.28% |
| 2013 FY | 72.17 Billion HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -118299.667% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | -2225.27% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -98758.271% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -23638.528% |
| Qianhai Health Holdings Limited | 94 Million HKD | -179108.55% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -18012.787% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -18539.622% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -25217.733% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -24327.053% |
| SSY Group Limited | 4.49 Billion HKD | -3648.643% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -45833.207% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | -15348.174% |